Rituximab-HCVAD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab-HCVAD, covering 2020-06-02 to 2020-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger [Phase 2]